Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Org Biomol Chem ; 21(4): 715-718, 2023 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-36412116

RESUMO

We report the use of halogen bonding (XB) for the generation of aryl radicals from aryl halides under blue light irradiation and applied it in radical generation/1,5-hydrogen-atom transfer/radical cyclization cascade reactions for the synthesis of oxindoles and isoindolinones. On the basis of experimental studies, we propose that DBU can serve as a suitable XB acceptor with aryl halides for the formation of a photoactive electron donor and acceptor complex.

2.
Org Biomol Chem ; 20(38): 7599-7603, 2022 10 05.
Artigo em Inglês | MEDLINE | ID: mdl-36148776

RESUMO

A catalytic charge transfer complex strategy that enabled difluoromethylation and ethoxycarbonylmonofluoromethylation of enamides with phosphonium bromine salts has been reported. This strategy also provides a convenient approach for the synthesis of functionalized oxindoles and 1,1-diphenylethylenes with easily available phosphonium bromine salts and a catalytic amount of iodine anion.


Assuntos
Brometos , Iodo , Bromo , Oxindóis , Sais
3.
Org Biomol Chem ; 14(6): 2007-14, 2016 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-26755065

RESUMO

The chiral N-heterocyclic carbene-catalyzed [3 + 2] annulation of α-bromoenals and 3-aminooxindoles was developed, giving the corresponding spirocyclic oxindolo-γ-lactams in good yields with high diastereoselectivities and enantioselectivities.


Assuntos
Compostos Heterocíclicos/química , Hidrocarbonetos Bromados/química , Indóis/química , Lactamas/síntese química , Metano/análogos & derivados , Compostos de Espiro/síntese química , Catálise , Lactamas/química , Metano/química , Estrutura Molecular , Compostos de Espiro/química
4.
J Org Chem ; 80(11): 5900-5, 2015 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-25933360

RESUMO

The enantioselective N-heterocyclic carbene-catalyzed [4 + 2] cyclocondensation of α-chloroaldehydes and trifluoromethyl N-Boc azadienes was developed, giving the corresponding 3,4-disubstituted-6-trifluoromethyldihydropyridin-2(1H)-ones in good yields with exclusive cis-selectivities and excellent enantioselectivities.

5.
Org Biomol Chem ; 13(24): 6694-7, 2015 Jun 28.
Artigo em Inglês | MEDLINE | ID: mdl-26006112

RESUMO

The chiral N-heterocyclic carbene-catalyzed [4 + 2] cyclization of α-chloroaldehydes and arylidene indanediones was developed, giving the corresponding indenopyrones in good yields with high diastereoselectivities and enantioselectivities.


Assuntos
Aldeídos/química , Compostos Heterocíclicos/química , Indenos/síntese química , Metano/análogos & derivados , Pironas/síntese química , Aldeídos/síntese química , Catálise , Ciclização , Halogenação , Compostos Heterocíclicos/síntese química , Indenos/química , Metano/síntese química , Metano/química , Pironas/química , Estereoisomerismo
6.
Yao Xue Xue Bao ; 50(8): 931-44, 2015 Aug.
Artigo em Zh | MEDLINE | ID: mdl-26668991

RESUMO

The study of peptide drugs has been an important direction in research and development of new drugs. However, lots of natural macromolecular peptides are limited in clinical use by their metabolic instability and low bioavailability. In recent years, the active small peptidomimetics open up a new hotspot of peptide drug development with the characteristics of low molecular weight, high bioactivity and structural modification. Many peptidomimetics are on the market or on the clinical study. This paper elaborated the small peptidomimetics approved by American Food and Drug Administration (FDA) from 2005 to 2014, and reviewed their researching status with source, synthetic method, chemical structure, marketing time, indication, clinical efficacy and safety. Research prospects in this field were discussed.


Assuntos
Peptidomiméticos , Pesquisa Biomédica/tendências , Estados Unidos , United States Food and Drug Administration
7.
PLoS Negl Trop Dis ; 17(7): e0011215, 2023 07.
Artigo em Inglês | MEDLINE | ID: mdl-37410790

RESUMO

BACKGROUND: Praziquantel (PZQ) has been the first line antischistosomal drug for all species of Schistosoma, and the only available drug for schistosomiasis japonica, without any alternative drugs since the 1980s. However, PZQ cannot prevent reinfection, and cannot cure schistosomiasis thoroughly because of its poor activity against juvenile schistosomes. In addition, reliance on a single drug is extremely dangerous, the development and spread of resistance to PZQ is becoming a great concern. Therefore, development of novel drug candidates for treatment and control of schistosomiasis is urgently needed. METHODOLOGYS/PRINCIPAL FINDINGS: One of the PZQ derivative christened P96 with the substitution of cyclohexyl by cyclopentyl was synthesized by School of Pharmaceutical Sciences of Shandong University. We investigated the in vitro and in vivo activities of P96 against different developmental stages of S. japonicum. Parasitological studies and scanning electron microscopy were used to study the primary action characteristics of P96 in vitro. Both mouse and rabbit models were employed to evaluate schistosomicidal efficacy of P96 in vivo. Besides calculation of worm reduction rate and egg reduction rate, quantitative real-time PCR was used to evaluate the in vivo antischistosomal activity of P96 at molecular level. In vitro, after 24h exposure, P96 demonstrated the highest activities against both juvenile and adult worm of S. japonicum in comparison to PZQ. The antischistosomal efficacy was concentration-dependent, with P96 at 50µM demonstrating the most evident schistosomicidal effect. Scanning electron microscopy demonstrated that P96 caused more severe damages to schistosomula and adult worm tegument compared to PZQ. In vivo, our results showed that P96 was effective against S. japonicum at all developmental stages. Notably, its efficacy against young stage worms was significantly improved compared to PZQ. Moreover, P96 retained the high activity comparable to PZQ against the adult worm of S. japonicum. CONCLUSIONS: P96 is a promising drug candidate for chemotherapy of schistosomiasis japonica, which has broad spectrum of action against various developmental stage, potentially addressing the deficiency of PZQ. It might be promoted as a drug candidate for use either alone or in combination with PZQ for the treatment of schistosomiasis.


Assuntos
Praziquantel , Esquistossomose Japônica , Esquistossomicidas , Animais , Camundongos , Coelhos , Microscopia Eletrônica de Varredura , Praziquantel/análogos & derivados , Praziquantel/farmacologia , Schistosoma japonicum/efeitos dos fármacos , Esquistossomose Japônica/tratamento farmacológico , Esquistossomicidas/farmacologia
8.
Chem Sci ; 8(3): 1936-1941, 2017 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-28451308

RESUMO

The N-heterocyclic carbene-catalyzed oxidative [3 + 2] annulation of dioxindole and enals was developed, giving the corresponding spirocyclic oxindole-γ-lactones in good yields with high to excellent diastereo- and enantioselectivities. The challenging aliphatic enals worked effectively using this strategy. The oxidative cross coupling of homoenolate and enolate via single electron transfer was proposed as the key step for the reaction.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA